세계의 DNA 복구 약물 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 약물 유형별, 용도별, 유통 채널별, 지역별, 경쟁 시장별(2020-2030년)
DNA Repair Drugs Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type, By Application, By Distribution Channel, By Region & Competition, 2020-2030F
상품코드:1698050
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
DNA 복구 약물 세계 시장 규모는 2024년 78억 5,000만 달러에 달했고, 예측 기간 동안 12.85%의 연평균 복합 성장률(CAGR)로 성장하여 2030년까지 강력한 성장이 예상됩니다.
세계 DNA 복구제 시장은 제약 및 헬스케어 산업에서 역동적이고 빠르게 발전하고 있는 분야로, DNA 복구제는 세포의 DNA 이상을 표적으로 삼아 이를 교정하도록 설계된 특수한 약물의 한 유형입니다. 이러한 의약품은 DNA 손상이나 돌연변이가 질병 진행의 주요 원인이 되는 유전성 질환 및 다양한 암 치료에 중요한 역할을 하고 있습니다. 이 시장 개요는 세계 DNA 치료제 시장을 형성하는 주요 요인, 동향, 과제 및 기회에 대한 통찰력을 제공합니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
78억 5,000만 달러
시장 규모 : 2030년
162억 5,000만 달러
CAGR : 2025-2030년
12.85%
급성장 부문
종양학
최대 시장
북미
시장 성장 촉진요인
암 발병률 증가
주요 시장 이슈
DNA 복구 메커니즘의 복잡성
주요 시장 동향
정밀의료와 맞춤치료
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 DNA 복구 약물 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
약제 유형별(알킬화제, PARP 억제제, 토포이소메라제 억제제, 기타)
용도별(신경 퇴행성 질환, 종양, 심혈관 질환, 뇌졸중)
유통 채널별(소매 약국, 병원 약국, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 DNA 복구 약물 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 DNA 복구 약물 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 DNA 복구 약물 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 DNA 복구 약물 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 DNA 복구 약물 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
제품 출시
인수합병(M&A)
제13장 세계의 DNA 복구 약물 시장 : SWOT 분석
제14장 경쟁 구도
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Abbvie Inc.
Pfizer Inc.
Astrazeneca plc
Sanofi S.A.
Bayer AG
Gilead Sciences Inc.
Merck & Co. Inc.
Novartis AG
제15장 전략적 제안
제16장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
Global DNA Repair Drugs Market was valued at USD 7.85 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 12.85% through 2030. The Global DNA Repair Drugs Market is a dynamic and rapidly evolving segment of the pharmaceutical and healthcare industry. DNA repair drugs are a specialized category of medications designed to target and correct abnormalities in the DNA of cells. These drugs play a critical role in the treatment of genetic diseases and various forms of cancer, where DNA damage and mutations are key drivers of disease progression. This market overview provides insights into the key factors, trends, challenges, and opportunities shaping the landscape of the Global DNA Repair Drugs Market.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.85 Billion
Market Size 2030
USD 16.25 Billion
CAGR 2025-2030
12.85%
Fastest Growing Segment
Oncological
Largest Market
North America
Key Market Drivers
Increasing Cancer Incidence
The global population is aging, and this demographic shift has a significant impact on cancer incidence. Cancer can occur at any age; however, its prevalence increases significantly with aging. In 2022, approximately 53% of diagnosed cancer cases were in individuals aged 65 and above, highlighting the strong correlation between aging populations and rising cancer incidence. With increasing age, individuals are more susceptible to genetic mutations that can lead to cancer. As the elderly population grows, so does the prevalence of cancer, creating a substantial demand for innovative treatments like DNA repair drugs. Modern lifestyles often involve exposure to numerous cancer risk factors, including poor dietary habits, sedentary lifestyles, and increased consumption of tobacco and alcohol. Research indicates that 90-95% of cancer cases can be attributed to environmental and lifestyle factors, emphasizing a significant preventable risk component. These lifestyle choices contribute to the rise in cancer cases. DNA repair drugs are seen as potential solutions to address the genetic damage caused by such risk factors.
Key Market Challenges
Complexity of DNA Repair Mechanisms
One of the primary challenges in the development of DNA repair drugs is the intricate nature of DNA repair mechanisms. DNA repair is a highly regulated and multifaceted process involving various enzymes, pathways, and checkpoints. Different types of DNA damage require specific repair mechanisms. Designing drugs that can effectively target and modulate these complex processes while minimizing off-target effects is a formidable task. Additionally, DNA repair mechanisms vary between individuals, making it challenging to create a one-size-fits-all solution. Personalized medicine approaches require tailoring treatments to an individual's genetic profile, further complicating drug development and clinical trials.
Key Market Trends
Precision Medicine and Personalized Treatment
One of the most significant trends in the DNA Repair Drugs Market is the shift towards precision medicine. Advances in genomics and molecular diagnostics have enabled healthcare providers to tailor treatment plans to an individual's genetic profile. This trend recognizes that each patient's genetic makeup is unique, influencing their response to DNA repair drugs and other therapies. By identifying specific genetic mutations and DNA repair deficiencies in patients, healthcare professionals can select the most appropriate DNA repair drugs or combination therapies. This approach maximizes treatment efficacy while minimizing side effects, representing a paradigm shift in healthcare towards personalized, patient-centric treatments.
Key Market Players
GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Abbvie Inc.
Pfizer Inc.
Astrazeneca plc
Sanofi S.A.
Bayer AG
Gilead Sciences Inc.
Merck & Co. Inc.
Novartis AG
Report Scope:
In this report, the Global DNA Repair Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
DNA Repair Drugs Market, By Drug Type:
Alkylating Agents
PARP Inhibitors
Topoisomerase Inhibitors
Other
DNA Repair Drugs Market, By Application:
Neurodegenerative Diseases
Oncological
Cardiovascular Diseases
Stroke
DNA Repair Drugs Market, By Distribution Channel:
Retail Pharmacies
Hospital Pharmacies
Others
DNA Repair Drugs Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global DNA Repair Drugs Market.
Available Customizations:
Global DNA Repair Drugs market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global DNA Repair Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Type (Alkylating Agents, PARP Inhibitors, Topoisomerase Inhibitors, Other)
5.2.2. By Application (Neurodegenerative Diseases, Oncological, Cardiovascular Diseases, Stroke)
5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America DNA Repair Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Type
6.2.2. By Application
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States DNA Repair Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Type
6.3.1.2.2. By Application
6.3.1.2.3. By Distribution Channel
6.3.2. Canada DNA Repair Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Type
6.3.2.2.2. By Application
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico DNA Repair Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Type
6.3.3.2.2. By Application
6.3.3.2.3. By Distribution Channel
7. Europe DNA Repair Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Type
7.2.2. By Application
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany DNA Repair Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Type
7.3.1.2.2. By Application
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom DNA Repair Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Type
7.3.2.2.2. By Application
7.3.2.2.3. By Distribution Channel
7.3.3. Italy DNA Repair Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Type
7.3.3.2.2. By Application
7.3.3.2.3. By Distribution Channel
7.3.4. France DNA Repair Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Type
7.3.4.2.2. By Application
7.3.4.2.3. By Distribution Channel
7.3.5. Spain DNA Repair Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Type
7.3.5.2.2. By Application
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific DNA Repair Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Type
8.2.2. By Application
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China DNA Repair Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Type
8.3.1.2.2. By Application
8.3.1.2.3. By Distribution Channel
8.3.2. India DNA Repair Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Type
8.3.2.2.2. By Application
8.3.2.2.3. By Distribution Channel
8.3.3. Japan DNA Repair Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Type
8.3.3.2.2. By Application
8.3.3.2.3. By Distribution Channel
8.3.4. South Korea DNA Repair Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Type
8.3.4.2.2. By Application
8.3.4.2.3. By Distribution Channel
8.3.5. Australia DNA Repair Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Type
8.3.5.2.2. By Application
8.3.5.2.3. By Distribution Channel
9. South America DNA Repair Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Type
9.2.2. By Application
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil DNA Repair Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Type
9.3.1.2.2. By Application
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina DNA Repair Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Type
9.3.2.2.2. By Application
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia DNA Repair Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Type
9.3.3.2.2. By Application
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa DNA Repair Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Type
10.2.2. By Application
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa DNA Repair Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Type
10.3.1.2.2. By Application
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia DNA Repair Drugs Market Outlook
